The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations

Stem Cell Research and Therapy

Volumn 3, Issue 3, 2012, Pages

  Ribeiro, Carlos A ^a   Fraga, Joana S ^a   Grãos, Mário ^b   Neves, Nuno M ^a   Reis, Rui L ^a   Gimble, Jeffrey M ^c   Sousa, Nuno ^a   Salgado, Antánio J ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b Biocant Center of Innovation in Biotechnology   (Portugal)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; NERVE GROWTH FACTOR; SCATTER FACTOR; SECRETOME; SECRETORY PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; 3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; 3-(4,5-DIMETHYLTHIAZOL-2-YL)-5-(3-CARBOXYMETHOXYPHENYL)-2-(4-SULFOPHENYL)-2H-TETRAZOLIUM; NGF PROTEIN, HUMAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED STEM CELL; ARTICLE; CELL DENSITY; CELL ISOLATION; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL; WHARTON JELLY; ANIMAL; CELL COUNT; CELL SURVIVAL; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; NERVE CELL; PRIMARY CELL CULTURE; SECRETION (PROCESS); TIME; UMBILICAL CORD; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; CELL COUNT; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HIPPOCAMPUS; HUMANS; MESENCHYMAL STROMAL CELLS; NERVE GROWTH FACTOR; NEURONS; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; STEM CELL FACTOR; STEM CELLS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861667226     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt109     Document Type: Article

References (24)

1. Bone marrow derived mesenchymal stromal cells for the repair of central nervous system injury. Parr AM, Tator CH, Keating A, Bone Marrow Transp 2007 40 609 619 10.1038/sj.bmt.1705757 (Pubitemid 47456475)
2. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Salgado AJ, Reis RL, Sousa NJ, Gimble JM, Curr Stem Cell Res Ther 2010 5 103 110 10.2174/157488810791268564 19941460
3. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Carvalho MM, Teixeira FG, Reis RL, Sousa N, Salgado AJ, Curr Stem Cell Res Ther 2011 6 221 228 10.2174/157488811796575332 21476975
4. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Cun-Gang F, Qing-jun Z, Jing-ru Z, Stem Cell Rev 2011 7 195 207 10.1007/s12015-010-9168-8 20676943
5. Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation. Salgado AJ, Fraga JS, Mesquita AR, Neves NM, Reis RL, Sousa N, Stem Cells Dev 2010 19 1067 1074 10.1089/scd.2009.0279 19705968
6. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT, Kim SH, Brain Res 2008 1229 233 248 18634757
7. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ, Su CY, Li H, Neurobiol Dis 2007 27 339 353 10.1016/j.nbd.2007.06.010 17651977 (Pubitemid 47337188)
8. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS, PLoS One 2008 3 3336 10.1371/journal.pone.0003336 18852872
9. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D, Stem Cells 2006 24 781 792 10.1634/stemcells.2005-0330 16223852 (Pubitemid 44464783)
10. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL, Circulation 2004 109 1292 1298 10.1161/01.CIR.0000121425.42966.F1 14993122 (Pubitemid 38372789)
11. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR, Am J Physiol Regul Integr Comp Physiol 2006 291 880 884 10.1152/ajpregu.00280.2006 16728464 (Pubitemid 44498426)
12. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Salto Y, Tamai K, Ogihara T, Kaneda Y, Arterioscler Thromb Vasc Biol 2005 25 2542 2547 10.1161/01.ATV.0000190701.92007.6d 16224047 (Pubitemid 43732276)
13. Slowed progression in models of Huntington disease by adipose tissue stem cells transplantation. Lee ST, Chu K, Jung KH, Im WS, Park JE, Lim HC, Won CH, Shin SH, Lee SK, Kim M, Roh JK, Ann Neurol 2009 66 671 681 19938161
14. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Lu S, Lu C, Han Q, Li J, Liao L, Zhao RC, Toxicology 2011 279 189 195 10.1016/j.tox.2010.10.011 21040751
15. AMP-activated kinase mediates adipose tissue stem cell-stimulated neuritogenesis of PC12 cells. Tan B, Luan Z, Wei X, He G, Wei G, Johnstone BH, Farlow M, Du Y, Neuroscience 2011 181 40 47 21352901
16. The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Wei X, Du Z, Zhao L, Feng D, Wei G, He Y, Tan J, Lee WH, Hampel H, Dodel R, Johnstone BH, March KL, Farlow MR, Du Y, Stem Cells 2009 27 478 488 10.1634/stemcells.2008-0333 19023032
17. Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Dubois SG, Floyd EZ, Zvonic S, Kilroy G, Wu X, Carling S, Halvorsen YD, Ravussin E, Gimble JM, Method Mol Biol 2008 449 69 79 10.1007/978-1-60327-169-1-5
18. Human umbilical cord perivascular cells (HUCPV) cells: a source of mesenchymal progenitors. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE, Stem Cells 2005 23 220 229 10.1634/stemcells.2004-0166 15671145 (Pubitemid 40239517)
19. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Zvonic S, Lefevre M, Kilroy G, Floyd ZE, DeLany JP, Kheterpal I, Gravois A, Dow R, White A, Wu X, Gimble JM, Mol Cell Proteomics 2007 6 18 28 17018519 (Pubitemid 46152688)
20. Quantification of protein isoforms in mesenchymal stem cells by reductive dimethylation of lysines in intact proteins. She YM, Rosu-Myles M, Walrond L, Cyr TD, Proteomics 2012 12 369 379 10.1002/pmic.201100308 22144135
21. The adaptation of human embryonic stem cells to different feeder-free culture conditions is accompanied by a mitochondrial response. Ramos-Mejia V, Bueno C, Roldan M, Sanchez L, Ligero G, Menendez P, Martin M, Stem Cells Dev 2012 21 1145 1155 10.1089/scd.2011.0248 21671728
22. Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification. Ramos-Mejía V, Fernández AF, Ayllán V, Real PJ, Bueno C, Anderson P, Martín F, Fraga MF, Menendez P, Stem Cells & Dev 2011 22619684
23. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Sánchez L, Gutierrez-Aranda I, Ligero G, Rubio R, Mũoz-Lápez M, García-Pérez JL, Ramos V, Real PJ, Bueno C, Rodríguez R, Delgado M, Menendez P, Stem Cells 2011 29 251 262 10.1002/stem.569 21732483
24. Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation. Sánchez L, Gutierrez-Aranda I, Ligero G, Martín M, Ayllán V, Real PJ, Ramos-Mejía V, Bueno C, Menendez P, Tissue Eng Part C Methods 2012 18 387 396 10.1089/ten.tec.2011.0546 22136131